Growth Metrics

Nexgel (NXGL) Research & Development (2021 - 2025)

Nexgel posted quarterly Research & Development of -$6000.0 for Q4 2025, down 185.71% on a QoQ basis from $7000.0 in Q3 2025.

Nexgel (NXGL) has 5 years of Research & Development data on file, last reported at -$6000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Research & Development changed N/A year-over-year to -$6000.0; the trailing twelve-month figure through Dec 2025 stood at $2000.0 (down 97.44% YoY), and the FY2025 full-year result was $2000.0, down 97.44% from the prior year.
  • Research & Development for Q4 2025 stood at -$6000.0, down from $7000.0 in the prior quarter.
  • Across five years, Research & Development topped out at $193000.0 in Q3 2022 and bottomed at -$6000.0 in Q4 2025.
  • The 5-year median for Research & Development is $13500.0 (2021), against an average of $36312.5.
  • The widest annual swing landed in 2022, when Research & Development jumped 1010.0%; it then tumbled 96.89% in 2023.
  • A 5-year view of Research & Development shows it stood at $14000.0 in 2021, then soared by 178.57% to $39000.0 in 2022, then sank by 66.67% to $13000.0 in 2023, then surged by 484.62% to $76000.0 in 2024, then plunged by 107.89% to -$6000.0 in 2025.
  • The last three Research & Development figures came in at -$6000.0 (Q4 2025), $7000.0 (Q3 2025), and $1000.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 361.90 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 249.00 Mn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 94.27 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 15.80 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 189.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 44.30 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 98.66 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 139.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -
10 Nexgel 31,199.58 -1.34 Mn 819,000.00 -6,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -6,000.00
Sep 30, 2025 7,000.00
Mar 31, 2025 1,000.00
Jun 30, 2024 76,000.00
Mar 31, 2024 2,000.00
Dec 31, 2023 13,000.00
Sep 30, 2023 6,000.00
Jun 30, 2023 55,000.00
Mar 31, 2023 29,000.00
Dec 31, 2022 39,000.00
Sep 30, 2022 193,000.00
Jun 30, 2022 111,000.00
Mar 31, 2022 24,000.00
Dec 31, 2021 14,000.00
Jun 30, 2021 10,000.00
Mar 31, 2021 7,000.00